{"success":true,"data":{"pressRelease":{"id":"13946","rtpr_id":"nNFCbGpBqX","ticker":"IRON","exchange":"NASDAQ","all_tickers":["IRON"],"title":"ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON","author":"Newsfile Corp","published_at":"2026-04-29T21:32:16.135Z","article_body":"New York, New York--(Newsfile Corp. - April 29, 2026) - WHY: Rosen Law Firm,\na global investor rights law firm, continues to investigate potential\nsecurities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ:\nIRON) resulting from allegations that Disc Medicine, Inc. may have issued\nmaterially misleading business information to the investing public.\n\nSO WHAT: If you purchased Disc Medicine, Inc. securities you may be entitled\nto compensation without payment of any out of pocket fees or costs through a\ncontingency fee arrangement. The Rosen Law Firm is preparing a class action\nseeking recovery of investor losses.\n\nWHAT TO DO NEXT: To join the prospective class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=56641 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nWHAT IS THIS ABOUT: On February 13, 2026, the U.S. Food and Drug\nAdministration (\"FDA\") issued a Complete Response Letter (\"CRL\") to Disc\nMedicine regarding its bitopertin program. The FDA stated they could not\napprove Disc Medicine's new drug application (\"NDA\") as there were\nuncertainties in the NDA that would need additional evidence.\n\nOn this news, Disc Medicine's stock price fell 22% on February 13, 2026.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually litigate securities class actions. Be wise\nin selecting counsel. The Rosen Law Firm represents investors throughout the\nglobe, concentrating its practice in securities class actions and shareholder\nderivative litigation. Rosen Law Firm achieved, at that time, the largest ever\nsecurities class action settlement against a Chinese Company. Rosen Law Firm\nwas Ranked No. 1 by ISS Securities Class Action Services for number of\nsecurities class action settlements in 2017. The firm has been ranked in the\ntop 4 each year since 2013 and has recovered hundreds of millions of dollars\nfor investors. In 2019 alone the firm secured over $438 million for investors.\nIn 2020, founding partner Laurence Rosen was named by law360 as a Titan of\nPlaintiffs' Bar. Many of the firm's attorneys have been recognized by\nLawdragon and Super Lawyers.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\n\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/295012","article_body_html":"","raw_payload":{"data":{"id":"nNFCbGpBqX","title":"ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON","author":"Newsfile Corp","ticker":"IRON","created":"2026-04-29T21:32:16.135Z","tickers":["IRON"],"exchange":"NASDAQ","article_body":"New York, New York--(Newsfile Corp. - April 29, 2026) - WHY: Rosen Law Firm,\na global investor rights law firm, continues to investigate potential\nsecurities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ:\nIRON) resulting from allegations that Disc Medicine, Inc. may have issued\nmaterially misleading business information to the investing public.\n\nSO WHAT: If you purchased Disc Medicine, Inc. securities you may be entitled\nto compensation without payment of any out of pocket fees or costs through a\ncontingency fee arrangement. The Rosen Law Firm is preparing a class action\nseeking recovery of investor losses.\n\nWHAT TO DO NEXT: To join the prospective class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=56641 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nWHAT IS THIS ABOUT: On February 13, 2026, the U.S. Food and Drug\nAdministration (\"FDA\") issued a Complete Response Letter (\"CRL\") to Disc\nMedicine regarding its bitopertin program. The FDA stated they could not\napprove Disc Medicine's new drug application (\"NDA\") as there were\nuncertainties in the NDA that would need additional evidence.\n\nOn this news, Disc Medicine's stock price fell 22% on February 13, 2026.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually litigate securities class actions. Be wise\nin selecting counsel. The Rosen Law Firm represents investors throughout the\nglobe, concentrating its practice in securities class actions and shareholder\nderivative litigation. Rosen Law Firm achieved, at that time, the largest ever\nsecurities class action settlement against a Chinese Company. Rosen Law Firm\nwas Ranked No. 1 by ISS Securities Class Action Services for number of\nsecurities class action settlements in 2017. The firm has been ranked in the\ntop 4 each year since 2013 and has recovered hundreds of millions of dollars\nfor investors. In 2019 alone the firm secured over $438 million for investors.\nIn 2020, founding partner Laurence Rosen was named by law360 as a Titan of\nPlaintiffs' Bar. Many of the firm's attorneys have been recognized by\nLawdragon and Super Lawyers.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\n\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/295012"},"type":"article","timestamp":"2026-04-29T21:32:16.178688538Z","server_sent_at_ms":1777498336178},"received_at":"2026-04-29T21:32:16.231Z","source_url":"https://www.newsfilecorp.com/release/295012"},"analysis":null,"durationMs":null,"modelName":null}}